ABSTRACT: Background. Treatments for head and neck squamous cell carcinoma (HNSCC) are associated with toxicities that lead to emergency department presentation. Methods. We utilized data from an ongoing prospective cohort of newly diagnosed, previously untreated patients (N 5 298) with HNSCC to evaluate the association between clinical and epidemiologic factors and risk for and frequency of emergency department presentation. Time to event was calculated from the date of treatment initiation to emergency department presentation, date of death, or current date. Frequency of emergency department presentation was the sum of emergency department visits during the follow-up time.
INTRODUCTION
Head and neck cancer is the sixth most common malignancy globally. 1 Nearly 90% of these tumors are classified as head and neck squamous cell carcinoma (HNSCC) and include cancer of the oral cavity, pharynx, and larynx. Survival rates for HNSCC are quite high when treated in early stages (5-year survival of approximately 75%), 1 however, many patients present with metastatic disease at diagnosis, resulting in a reduced survival of approximately 35%. 1, 2 Advances in HNSCC treatment have improved survival even at advanced stages. 3 However, these treatments are associated with significant toxicities that compromise patient functionality and quality of life and present significant management challenges for the clinical staff. 2, 4 Emergency departments are now a frequent site of care for many patients with cancer. 5 Visiting the emergency department may potentially reflect inadequacy in addressing or managing expected side effects or complications during routine care. 5 Additionally, emergency department visits increase the cost of care, result in unplanned hospitalizations and breaks in treatment, and are associated with poor overall survival and other cancer-related outcomes. 5, 6 In the present study, we used an ongoing prospective cohort of patients (N 5 298) with HNSCC to determine the chief complaints during emergency department visits, risk for emergency department visits after treatment initiation, and frequency of emergency department visits. We assessed the importance of clinical, epidemiologic, and behavioral factors associated with their emergency department presentation with the aim of identifying modifiable risk factors associated with overall cancer-related outcomes.
MATERIALS AND METHODS

Study population
The study population consisted of participants in an ongoing prospective cohort study of HNSCC at The University of Texas MD Anderson Cancer Center (MD Anderson). These patients were newly diagnosed with histologically confirmed HNSCC and were being treated at MD Anderson. This study was approved by the Institutional Review Board at MD Anderson, and informed consent was obtained from each patient.
Exclusions and eligibility
This study includes newly diagnosed patients (with no medical history of cancer or previous cancer treatment) over the age of 18 years with locoregional HNSCC being treated at MD Anderson. Patients were English or Spanish speaking and were able to provide written informed consent. Patients were excluded from the study if they had distant metastasis or were participating in clinical trials for pain. Additionally, 9 individuals withdrew from the study to receive treatment outside MD Anderson and were excluded from the present analysis. A total of 298 individuals were included in the present study.
Study setting
The Multidisciplinary Head and Neck Cancer Center. Patients first present to the center for treatment evaluation. A multidisciplinary team of surgical physicians, medical physicians, radiation oncologists, dental oncologists, speech language pathologists, nutritionists, and social workers performed consultations to recommend the best treatment option for each patient. Trained MD Anderson staff administered informed consent and questionnaires to patients before evaluation by clinicians. Data were collected at baseline, weekly during treatment, and during clinic visits.
Emergency department. Established in 2010 as the first academic department of emergency medicine at a comprehensive cancer center, the MD Anderson emergency department has 44 beds. In 2014, the department received more than 20,000 patient visits. The data related to each emergency department visit include primary and secondary presenting symptoms/complaints, number and frequency of emergency visits, symptom severity, disposition (discharged or admitted to hospital/intensive care unit), and discharge diagnosis.
Epidemiology and clinical data collection at presentation to the cancer center Trained MD Anderson staff administered questionnaires to patients presenting at the Head and Neck Center before being seen by the clinicians. The questionnaires were developed by an interdisciplinary team of epidemiologists, behavioral scientists, and medical oncologists in order to understand the epidemiology of the different types and cancers and the underlying factors associated with cancer risk, progression, and survival. Clinical data were abstracted from the patients' medical charts.
Outcome variables
Chief complaints and discharge diagnoses. The chief complaint is the stated reason for the emergency department visit captured when the patient arrives in the emergency department. There is no standard nomenclature or coding mechanism for emergency department chief complaints. In order to clean and standardize the chief complaint fields, we utilized previously described categories for emergency department visits in patients with cancer to categorize the chief complaints into 11 broad categories (see Table 1)   5 ; gastrointestinal, bleeding, cardiovascular, fever, injury, malaise, neurologic, pain, respiratory, syncope, and other.
The International Classification of Diseases, ninth revisions (ICD-9) is the system of assigning codes to diagnoses and procedures associated with hospital use in the United States. Generally, emergency department visits are assigned more than one ICD-9 per visit. For this study, we evaluated ICD-9 codes in positions 1 to 5 for the purpose of describing the top discharge diagnoses associated with the primary chief complaints. ICD-9 codes associated with the tumor (ICD-9 codes 140-239 "neoplasms") were not included as all the study subjects were known to have head and neck cancer.
Risk for and frequency of emergency department visits
For the descriptive analysis, individuals were coded as 0 if they had no emergency department visits, and 1 if they had at least 1 emergency department visit after treatment initiation. Follow-up time was defined as the time from treatment initiation to the first emergency Because of the small number of patients in the underweight category (N 5 9), underweight and normal weight participants were combined. Previous studies and our preliminary analysis suggested that higher BMI is protective against adverse cancer-related outcomes. 7 Therefore, we dichotomized BMI as overweight/obese versus normal/ underweight, and used the overweight/obese category as the reference in the analysis. Depression, alcohol use, smoking status (never/ever), fatigue, and pain were also assessed. We used a single item measure to assess fatigue ("during the past 4 weeks, did you have a lot of energy?"). Depression was assessed using the Center for Epidemiologic Studies Depression (CESD) scale, which is a 20-question self-reported instrument, scored on a scale of 0 to 60, used to measure several functional domains commonly linked to depression. 8 The CESD score was calculated and a cutoff of 23 was used to define "probable depression" according to the literature. 9 Alcohol intake was categorized according to the number of drinks per week (0, 1-6, 7-13, or 141). Self-reported pretreatment pain was assessed on a scale of 0 to 10 (0 representing no pain). Because normality was not met, we used the National Comprehensive Cancer Network cutoff score of 7 for severe pain. Treatment modality was coded as surgery, radiation, or chemotherapy/chemoradiotherapy. Cancer stage was divided into categories according to the Surveillance, Epidemiology, and End Results program (in situ, localized, regional, distant site, and unknown/ unstaged). Because of the collinearity between treatment modality and cancer stage, we only included treatment in the present analysis. Analyses, including stage of disease instead of cancer treatment, are consistent with the findings described below.
Statistical analysis
We performed descriptive analyses of patient characteristics of those with no emergency department visits versus those with at least 1 emergency department visit. Chief complaints were assessed by the time to the first emergency department visit (<14 days, 14-29 days, 30-89 days, 90-179 days, and 1801 days). Top discharge diagnoses by ICD-9 category and top ICD-9 codes associated with the first emergency department visit were also described for those individuals with at least 1 emergency department visit.
We evaluated the role of the clinical and epidemiologic factors in risk of emergency department visits using the Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Predictors with a p value of < .10 in the univariate analysis and a priori selected predictors with suspected associations with clinical outcomes (age, sex, and ethnicity) were included in the multivariable analysis. Adherence to the Cox proportional hazards assumption was confirmed by plotting the Schoenfeld residuals.
Linear regression models were used to evaluate the association between clinical and epidemiologic factors and frequency of emergency department visits. We took the natural log of the frequency of emergency department visits to account for the nonnormal distribution of the emergency department visit data. In order to take into account individuals with 0 emergency department visits, "1" was added to the frequency of the emergency department visits for every subject. Univariate analysis, including follow-up time, was conducted to determine inclusion in the multivariable model. Variable selection was conducted in a similar manner to the time-to-event analysis.
Finally, we tested for multiplicative interactions between treatment type and the variables with significant associations in each analysis to account for potential residual confounding because of treatment. We included the cross product term of the treatment variable (chemotherapy/chemoradiotherapy vs other) and the predictors of interest in the multivariable model. The statistical significance of the interaction term was determined using the Wald statistic. All analyses were conducted using Stata statistical software version 14.0 (StataCorp LP, College Station, TX).
RESULTS
A total of 97 patients presented to the emergency department at least once in this study. Median time to the first emergency department presentation was 30 days with a mean time of approximately 52 days. Individuals who visited the emergency department during the study period presented to the emergency department between 1 and 6 times. The median frequency of emergency department presentation was 1 emergency department visit, with a mean of approximately 2 emergency department visits (1.86).
Chief complaints and discharge diagnoses
Distribution of the chief complaints according to the time to the first emergency department visit from treatment initiation is shown in Figure 1 . The most common chief complaints within 14 days of treatment initiation were gastrointestinal (29.03%) and pain (19.35%). Pain persisted as a top chief complaint associated with presentation to the emergency department past 180 days. Table 2 describes the top diagnosis categories, ICD-9 codes, and descriptions starting with the most frequently occurring, of the overall population with at least 1 emergency department visit and the subset of those admitted to the hospital or intensive care unit. The top diagnosis categories and ICD-9 codes were consistent between the 2 groups, with "symptoms" and "endocrine, nutritional, metabolic, immunity" categories being the most common discharge diagnosis categories.
Factors associated with emergency department presentation
Distribution of the patient characteristics between those who presented to the emergency department and those who did not are shown in Table 3 . Individuals with at least 1 emergency department visit were more likely to fall into the normal weight category according to BMI, be treated with chemotherapy/chemoradiotherapy, present with severe pain at baseline, have a history of hypertension, and be classified as having depression according to a CESD score of greater than or equal to 23 (p value < .03 for each). Distribution of sex was different between those who presented to the emergency department at least once and those who did not (27% women vs 18% men), however, the difference was not statistically significant (p value 5 .08).
Risk for emergency department presentation
Univariate and multivariable analysis for risk of emergency department presentation are shown in 
Frequency of emergency department presentation
Univariate and multivariable linear regression models for frequency of emergency department visits are shown in Table 5 . Treatment with chemotherapy/chemoradiotherapy (p 5 .02), severe pretreatment pain (p 5 .04), history of hypertension (p 5 .03), normal BMI (p 5 .04), and depression (p 5 .001) were all positively associated with the frequency of emergency department visits in the univariate analysis. Associations among normal BMI (p 5 .02) and severe pain (p 5 .02) and frequency of emergency department visits persisted after mutual adjustment in the multivariable analysis. Treatment with chemotherapy/ chemoradiotherapy (p 5 .09) and history of hypertension (p 5 .09) were marginally significant. No interactions were observed between treatment type and the significant predictors of emergency department visit frequency (not shown).
DISCUSSION
This is the first study to evaluate the association between clinical and epidemiologic factors and incidence of emergency department presentations in patients with HNSCC in a cohort study in the United States. A previous study in a Taiwanese population found that pain and gastrointestinal issues were the primary complaints for patients with head and neck cancer presenting to the emergency department, which is consistent with the findings from our study. 10 This study identifies gastrointestinal symptoms as the primary reason for emergency department presentation and one of the primary discharge diagnoses in this population, consistent with known symptoms of head and neck cancer treatment. 4, 11, 12 Dysphagia (impairment of the swallowing process) is common in patients with HNSCC, and is often underdiagnosed and improperly treated, 13 resulting in dehydration and malnutrition 14 and may necessitate the use of nonoral nutritional support. A recent study aimed at understanding the management and prevention of acute and late effects because of head and neck cancer therapy, in particular, treatment associated effects related to swallowing, suggested that precautions can be taken before, during, and after treatment in order to minimize the impact of dysphagia. 13 Radiation can also lead to nausea, vomiting, and mouth ulcers, which are often a source of gastrointestinal-related symptoms in this cancer population. 3, 11 Chemotherapy/chemoradiotherapy was marginally associated with the risk of and frequency of emergency department visits in this study. A majority (approximately 95%) of the chemotherapy/chemoradiotherapy group was comprised of patients being treated with chemoradiotherapy. Treatment for HNSCC is closely linked with the stage of the disease and overall health of the patient. 15 Treatment with chemoradiotherapy has been associated with a variety of toxicities (severe fever, neutropenia, anemia, mucositis, and hematologic toxicities). 16 Our study suggests that treatment could be associated with the risk or frequency of emergency department presentations and poorer overall cancer-related outcomes.
Pain is one of the first signs of head and neck cancer, and can be a result of the tumor itself or as a consequence of therapy. Up to 80% of patients with head and neck cancer report pain during treatment, and for nearly 40%, pain persists beyond treatment. 17 We found that pain persisted as a top chief complaint associated with presentation to the emergency department past 180 days from treatment initiation. However, the role of pain in treatment naive patient outcomes is less well understood. A recent study found that patients with head and neck cancer with lymph node metastases were more likely to report severe pretreatment pain compared with patients without lymph node involvement, and that this was significantly correlated with measures of overall quality of life and increased symptom burden. 4 Pretreatment pain has been associated with poorer overall survival in patients with HNSCC, 18 thus suggesting the need for prompt pain treatment and management.
Depression occurs in over 10% of patients with cancer 19 and results in higher rates of mortality in patients with cancer by up to 39%. 20 The negative influence of depression on nutritional status and quality of life in patients with head and neck cancer has been previously demonstrated. 21, 22 Baseline depression has been identified as a modifiable risk factor for malnutrition as a result of radiotherapy 22 and the close correlation between psychosocial status and nutrition has been well documented in other cancer sites. [23] [24] [25] [26] Literature suggests that depression can be reliably diagnosed in oncology settings and that antidepressant medications and brief psychotherapy are effective for 60% to 80% of those affected. 27, 28 Thus, the emergency department may be an important setting for screening for depression in this population.
The results of this study indicate that higher BMI may protect individuals from presentation to the emergency department, but history of hypertension, depression, and severe pain at diagnosis are positively associated with emergency department presentation and frequency. Although high BMI has been linked with higher risk of several cancers, the association between pretreatment BMI and cancer-related outcomes and survival are not consistent across cancer sites. 7, [29] [30] [31] A recent metaanalysis suggests that patients with head and neck cancer with higher BMI before treatment have better survival rates, lower recurrence rates, and better distant failure or metastasis-free survival rates compared with normal weight individuals. 7 Our results are consistent with these findings. Patients with head and neck cancer experience significant weight loss throughout treatment, which is an important predictor of HNSCC outcomes. 7, 32 Overweight and obese individuals may have higher nutritional reserves throughout therapy. Potentially, dietary interventions may be developed to maintain patient body weight throughout the course of treatment, in hopes of improving overall outcomes and reduce emergency department presentations in these patients.
Hypertension before cancer treatment has been associated with the development of myocardiopathy because of therapeutic agents used in cancer treatment. 33 Cardiotoxicity of cancer treatment is an important concern, with a history of hypertension as a risk factor. A State of Science report on cancer treatment-related cardiotoxicity suggests a need for clinical assessment of cardiovascular risk before treatment initiation. 34 Because of the association between the history of hypertension and the risk of emergency department presentation, we subsequently stratified each analysis by history of hypertension. These analyses yielded consistent results, however, we found that the association between BMI and emergency department presentation only persisted in the subset of patients without a history of hypertension (no history of hypertension: HR, 3.47; 95% CI, 1.55-7.79 vs history of hypertension: HR, 1.20; 95% CI, 0.64-2.26). These results suggest that history of hypertension is possibly a more important predictor of emergency department presentation than BMI. Further research is necessary to further elucidate the association among BMI, hypertension, and emergency department presentation.
The present study suggests that treatment modality, severe pretreatment pain, BMI, hypertension, and depression may be important predictors of emergency department presentation after treatment initiation and/or frequency of emergency department presentations. These factors have also been previously linked with HNSCC related outcomes; therefore, emergency department presentation may be a potential mediator between these factors and HNSCC outcomes. The emergency department may act as the first patient care delivery site where intervention may be applied to remediate the factors that are associated with poor HNSCC outcomes. In addition to being the first of its kind, this study utilizes prospective data to evaluate the role of pretreatment risk factors and clinical characteristics.
This study had limitations. First, the study had a relatively small sample size, which reduces the statistical power. However, a post-hoc sample size calculation using a failure (emergency department presentation) rate of approximately 33% suggests that 64 events and a total sample size of 200 are necessary to reach 80% power. Therefore, we believe the sample size of the present study is sufficient to detect meaningful associations that warrant further replication.
Information regarding human papillomavirus (HPV) status was missing, and previous studies have suggested differential cancer-related outcomes for patients with HPV-positive versus HPV-negative tumors. The study was also limited to patients with HNSCC at 1 tertiary care cancer center, and, therefore, these results may not be generalizable to other head and neck cancer populations. Additionally, it is possible that this study did not capture all emergency department visits (ie, if a patient went to an emergency department outside of MD Anderson). However, as these patients were being treated at MD Anderson, they were also likely to be referred back to the MD Anderson emergency department for care. Therefore, we do not believe this to be a common occurrence in this population. Another limitation was the lack of data on the specific etiology of pain. Future studies on the cause of pain, the cause of dehydration, and other emergency department-related presentations as well as those that led to a hospital admission are ongoing. It is important to highlight integration of dental oncology in the overall multidisciplinary care of these patients. Routinely, patients are evaluated before therapy by our dental oncology team. This consultation is driven by site and planned treatment of the cancer. For example, all patients requiring radiotherapy as part of their planned treatment are evaluated by our dental oncology experts. In our dataset, 240 patients received oral care and 58 did not. When we analyzed data on the impact of oral care on the frequency of emergency department visits, we found that patients who received oral care were less likely to visit the emergency department (Mann-Whitney U test statistics 5 5766.00, 2-sided, p 5 .018).
This study provides a snapshot of the predictors of emergency department presentation in patients with HNSCC in the United States. Further studies are necessary to validate our findings and provide mechanistic explanations for these associations. Efforts targeted at pain and gastrointestinal distress in specific subgroups of the HNSCC population (those with pretreatment depression, hypertension, and low BMI) may improve overall quality of life and cancer-related outcomes by avoiding emergency department presentations in these patients.
